Close Menu
    What's Hot

    New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

    October 28, 2026

    Q&A: Alexandr Dudarev, CEO, Inshurik

    October 28, 2026

    Interface Europe Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

    October 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Chariot Re Announces Fourth Reinsurance Transaction, First Covering Japanese Liabilities

      October 15, 2026

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026

      Is Dementia the Next Big Longevity Event?

      October 15, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

      October 28, 2026

      Interface Europe Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      October 22, 2026

      FirstGroup Pension Scheme Completes Bulk Purchase Annuity Transaction With Aviva

      October 16, 2026

      Metallus UK Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      October 14, 2026

      Record Low Mortality Rates So Far in 2026 in England and Wales, Says CMI

      October 12, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Household Capital Completes New Reverse Mortgage Securitisation

      October 22, 2026

      New Report Suggests Life Settlement Market Poised for Long-Term Expansion

      October 15, 2026

      Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

      October 15, 2026

      Global Equity Release Market Estimated To Hit $52 Billion by 2035

      October 12, 2026

      New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

      October 28, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026

      Interface Europe Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      October 22, 2026

      Household Capital Completes New Reverse Mortgage Securitisation

      October 22, 2026
    • Events
    • Latest Issues
      Life Risk News Editors Letter

      Editor’s Letter – Volume 2, Issue 10, October 2026

      October 15, 2026

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Editor’s Letter – Volume 3, Issue 1, January 2024

    Magazine January 10, 2024By Chris Wells
    Life Risk News Editors Letter
    Share
    Twitter LinkedIn Email

    Download Life Risk News Volume 3, Issue 1, January 2024

    Happy New Year. 

    Our first cover story of 2024 looks at what’s in store for the US pension risk transfer market this year. Aaron Woolner spoke to Sheena McEwen, Head of Distribution at Legal and General Retirement of America and Jake Pringle, Principal and Consulting Actuary at Milliman, to get their views in Still Plenty of Capacity for Growth in Robust US PRT Market. 

    Closed-ended funds are increasingly common in the life settlement market, but there are significant idiosyncrasies that investors need to know when deciding whether an open or closed-ended fund structure is right for them. Greg Winterton spoke to Jonas Martenson, Founder and Sales Director Ress Capital and Patrick McAdams, Investment Director at SL Investment Management to learn more in Closed-Ended Funds Becoming More Common in Life Settlements but Pros and Cons Not Clear Cut. 

    Last year was a year to forget – comparatively – for the life insurance insurtech space as rising interest rates put a dampener on investor demand for private markets strategies. Greg Winterton spoke to Robert Le, Senior Emerging Technology Analyst at PitchBook and Keith Raymond, Principal Analyst, Insurance, at Celent to see what the outlook might be in 2024 for the space in Life, Health-based Insurtech Pulls Back Again in 2023: Outlook Uncertain. 

    Body mass index is considered as one of the important vital signs in all medical records and all forms of insurance and life settlement applications screened for underwriting. Dr Rahul Nawander, Medical Director at Fasano Associates, digs into the impact of obesity on mortality in Risk Factors and Drivers of Mortality Associated with Body Mass Index and The Obesity Paradox, a guest article this month. 

    In early November last year, industry group the American Council of Life Insurers published its annual Life Insurers Fact Book, the organisation’s deep dive into a range of sub-categories of the US life insurance industry. Roger Lawrence, Managing Director of WL Consulting presents the main takeaways in ACLI 2023 Life Insurers Fact Book Shows Industry in Solid Shape, an analysis piece this month. 

    Scott Willkomm, CEO at life settlement provider, Life Equity, recently completed his term as Chair of the European Life Settlement Association. Greg Winterton spoke to Willkomm to get his thoughts on the progress ELSA has made during his tenure in this month’s Q&A. 

    The reverse mortgage market in the US has been on a multi-year decline, and recent higher interest rates haven’t helped. Greg Winterton spoke to Jarred Talmadge, Independent Consultant at JTTML Consulting to get his thoughts on the outlook for the market in 2024 in Interest Rates to Continue as Main Influence on US Reverse Mortgage Market Activity in 2024. 

    As always, I hope you enjoy the latest issue of Life Risk News and wish you every success for 2024. 

    Chris Wells
    Managing Editor
    Life Risk News

    2024 - January Editor's Letter Volume 3 Issue 1 - January 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Life Risk News Editors Letter

    Editor’s Letter – Volume 2, Issue 10, October 2026

    October 15, 2026By Chris Wells

    Editor’s Letter – Volume 2, Issue 9, September 2026

    September 9, 2026By Chris Wells

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026By Chris Wells

    Editor’s Letter – Volume 2, Issue 7, July 2026

    July 8, 2026By Chris Wells
    Latest Issue

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026

    Is Dementia the Next Big Longevity Event?

    October 15, 2026

    Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

    October 15, 2026

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.